Radicut edaravone regulatory update

FDA accepted an NDA from Mitsubishi for edavarone to treat amyotrophic lateral sclerosis. The PDUFA date is June 16, 2017. The IV cerebral neuroprotectant and free radical scavenger is marketed in Jap...